China Health Industries Holdings, Inc. 8-K/A
8-K/A · China Health Industries Holdings, Inc. · Filed May 16, 2024
Documents
- 8-K
AMENDMENT NO. 1 TO FORM 8-K
- EX-99.1
UNAUDITED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 OF HEILONGJIANG HEMPCAN PHARMACEUTICALS CO., LTD
- EX-99.2
AUDITED FINANCIAL STATEMENTS FOR THE FISCAL YEARS ENDED JUNE 30, 2023 AND 2022 OF HEILONGJIANG HEMPCAN PHARMACEUTICALS CO., LTD
- EX-99.3
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS AS OF AND FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023 AND THE YEAR ENDED JUNE 30, 2023 OF CHINA HEALTH INDUSTRIES HOLDINGS, INC
- EX-101.SCHchhe-20231201.xsd
XBRL SCHEMA FILE
- EX-101.LABchhe-20231201_lab.xml
XBRL LABEL FILE
- EX-101.PREchhe-20231201_pre.xml
XBRL PRESENTATION FILE
- XML
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-24-044152-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0205857-8ka1_china_htm.xml
IDEA: XBRL DOCUMENT